Status:
UNKNOWN
Impact of Specialist Led Integrated Care in COPD
Lead Sponsor:
Heart of England NHS Trust
Collaborating Sponsors:
AstraZeneca
Conditions:
COPD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will look at the impact of care delivery by a specialist respiratory doctor compared to general practitioners for patients with COPD in East Birmingham. The primary outcome will be to compa...
Detailed Description
This study will look at the impact of care delivery by a specialist respiratory doctor compared to general practitioners for patients with COPD in East Birmingham. It will be run from the Heart of Eng...
Eligibility Criteria
Inclusion
- Practices will be eligible for inclusion if they give consent to data collection and are part of the EBHO.
- Patients from the practices will be eligible if they are coded to have COPD within the GP record. In addition patients who are not coded to have COPD in the GP record, but who have a hospital admission with a primary diagnosis of COPD within the enrolment period for practices (first 3 months) will be eligible.
Exclusion
- • Patients will only be excluded if they are proven not to have COPD at specialist assessment, or during the follow up period, as determined by changes in medical coding within the GP record. If patients are assessed by the specialist and the diagnosis is not felt to be robust, enrolment will be suspended until this matter can be clarified by use of post bronchodilator spirometry and/or other required parts of their clinical care.
Key Trial Info
Start Date :
December 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03482700
Start Date
December 6 2017
End Date
March 1 2020
Last Update
October 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Sarah Pountain
Birmingham, West Midlands, United Kingdom, B9 5SS